VASCULAR PROSTHESIS SYSTEM AND MANUFACTURING PROCESS OF THE VASCULAR PROSTHESIS SYSTEM
Patent Information
- Application Number
- DE502015016967
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2014-07-16
- Filing Date
- 2015-07-15
- Publication Date
- 2024-11-14
- Estimated Expiration
- 2035-07-15
AI Technical Summary
Conventional vascular prostheses face challenges in reliably supporting blood vessel walls near branches without blocking them, particularly due to the need for precise positioning and alignment of fenestrated grafts, which is difficult and prone to blood leakage.
A vascular prosthesis system with defined perforation areas containing holes of specific diameters and closed edges, allowing for vascular support insertion while ensuring blood supply to branches and reliable sealing, using a combination of material design and agents influencing blood flow properties.
Enables easy positioning and secure sealing of vascular prostheses, ensuring adequate blood supply to branch vessels and preventing blood leakage, by using holes as both passage and closure devices, and adjusting blood flow properties with anticoagulants or blood thinners.
Description
[0001] The present invention relates to a vascular prosthesis system comprising a vascular prosthesis and a manufacturing method therefor.
[0002] For defects in the main vessels of the human body, particularly the aorta, it is known to insert vascular prostheses, also known as grafts, endografts, or stent grafts, into the blood vessel. Such defects include, for example, so-called aneurysms. Grafts are generally cylindrical in shape, at least when inserted. One problem with this treatment of the affected blood vessel is that several vessels usually branch off from the main vessels. If the defect is located near such a branch, reliable support of the vessel wall without simultaneously blocking the branch is not possible with conventional cylindrical grafts.
[0003] For this reason, vascular prostheses have been proposed in which a passage is cut out before insertion into the blood vessel, allowing a stent to be inserted into the vascular prosthesis and connected to it. A disadvantage of these so-called fenestrated vascular prostheses is that, firstly, the position of the branch relative to the position of the vascular prosthesis must be precisely determined before insertion. Secondly, positioning the vascular prosthesis is difficult because the passage must be precisely aligned with the branch once inserted.
[0004] DE 10 2012 103 987 A1 discloses a vascular prosthesis with a fenestration region. Furthermore, US 2013 / 0296998 A1 and US 2012 / 0046728 A1 disclose vascular prostheses with fenestrations.
[0005] Vascular stents are also proposed, in which the mesh size of the vascular prosthesis material is selected to be larger over a portion of the length of the vascular prosthesis. This area can then be aligned with the branch, and a balloon can be used to create a passage in the vascular prosthesis material. The larger mesh size simply serves to facilitate expansion using the balloon. However, inserting the wire on which the balloon is held remains difficult, as the mesh size cannot be selected too large to prevent unwanted leakage of blood from the vascular prosthesis and flow past the vascular prosthesis.
[0006] The invention is therefore based on the object of creating a solution which allows a simple manufacture of a vascular prosthesis and insertion of the vascular prosthesis into a main blood vessel and reliable sealing of the prosthesis edge zones, in particular in the area of the prosthesis branches, in a simple manner.
[0007] According to a first aspect of the invention, the object is achieved by a vascular prosthesis system comprising at least one vascular prosthesis for insertion into a blood vessel of a human body, wherein the vascular prosthesis has a proximal end, a distal end, and an elongated hollow cylindrical base body extending between the proximal and the distal end, said base body having a longitudinal axis c and a circumference b, which base body has a vascular prosthesis material for forming a circumferentially substantially closed sheath, wherein the vascular prosthesis material has a woven structure of interwoven threads and with a mesh density;In the vascular prosthesis system according to the invention, the vascular prosthesis further comprises in the vascular prosthesis material at least one perforation region located between the proximal and distal ends, having a plurality of holes which have a diameter x selected from a range of 1.0 mm to 1.3 mm, and wherein the plurality of holes have a closed circumferential edge, beyond which edge no prosthetic material extends in the direction of the holes beyond the edge.
[0008] The problem underlying the invention is completely solved in this way: The defined passages in the vascular prosthesis serve, on the one hand, as a passage for receiving a vascular support, thereby ensuring a sufficient blood supply to branch vessels, and, on the other hand, the defined passages close reliably when needed when inserted due to their size and their edge.
[0009] According to the invention, the vascular prosthesis system comprises a vascular prosthesis for insertion into a blood vessel, in particular a main blood vessel, for example, the aorta, of a human body. According to the invention, the vascular prosthesis system can preferably further comprise at least one vascular support. Furthermore, the vascular prosthesis system can comprise a device for delivering agents into the blood. Other devices necessary for inserting the vascular prosthesis, such as guidewires, balloon catheters, and the like, can be part of the vascular prosthesis system. Preferably, however, only the parts remaining in the human body, in particular the vascular prosthesis and vascular support, are referred to as parts of the vascular prosthesis system.
[0010] According to the invention, as well as generally in the prior art, a vascular prosthesis is defined as a generally hollow-cylindrical device which generally comprises (self-expanding) spring elements with shape memory, also referred to as stents, for support against the vessel wall. The vascular prosthesis is therefore also referred to as a graft, endograft, or stent graft. The vascular prosthesis comprises a vascular prosthesis material, which is, for example, Dacron or another fabric. The vascular prosthesis material forms the outer surface of the vascular prosthesis. Spring elements can be provided, e.g. sewn, in or on the vascular prosthesis material, which press the vascular prosthesis material against the vessel wall when the vascular prosthesis is inserted and thus hold the vascular prosthesis in position.
[0011] In this context, "vascular support" is understood to mean any structure suitable for supporting a vessel while keeping it open and anchored via the vascular prosthesis. According to a preferred embodiment, the vascular support is a covered stent.
[0012] The at least one hole provided in the vascular prosthesis according to the invention represents a closure device for sealing the vascular prosthesis material against blood penetration. "Sealing" the material of the vascular prosthesis is understood, in particular, to mean the creation of a seal that prevents unwanted blood from escaping from the vascular prosthesis and thus prevents unwanted blood from flowing past the vascular prosthesis. Surprisingly, it was discovered within the scope of the present invention that, contrary to normal expectations, the introduction / provision of one or more holes in the material of the vascular prosthesis can be used to specifically influence blood permeability.
[0013] In this context, the term "hole" refers to an opening that has a size larger than the mesh size of the vascular prosthesis material. At the same time, however, the hole is smaller than the diameter of a stent to be attached to the vascular prosthesis when inserted. The size or diameter x of the hole refers to the dimension of the hole in a state in which the hole is not (yet) widened. The hole is preferably round. However, it is also possible for the hole to have an oval, rectangular, or other shape.
[0014] Preferably, a plurality of holes are provided on the vascular prosthesis in the perforation region. These holes are preferably introduced into the material of the vascular prosthesis adjacent to one another. The region in which the holes are provided is therefore also referred to as the perforation region. The perforation region preferably extends only over part of the length of the vascular prosthesis and has a perforation region length a. In the circumferential direction, the perforation region can extend over the entire circumference b of the vascular prosthesis. It is understood that alternatively, the perforation region can be provided only on one half, one quarter, or another partial region of the circumference b of the vascular prosthesis.
[0015] By providing a closure device in the form of at least one hole on the vascular prosthesis, it is achieved, on the one hand, that a guide wire can be easily guided through the material of the vascular prosthesis, in particular through one of the holes, through the hole when the vascular prosthesis is inserted into the main blood vessel. On the other hand, the fact that the hole serves as a closure device prevents unwanted blood from escaping from the vascular prosthesis. Moreover, according to a further embodiment, several holes can preferably be provided, thereby reducing the requirements for positioning the vascular prosthesis in the main blood vessel, since the guide wire can be inserted through any of the provided holes.However, the provision of multiple holes is only possible with the vascular prosthesis according to the invention, since holes that are unused after a stent has been inserted into one of the holes serve as a closure device and thus seal the area around the stent. In addition, the present invention enables the stent to be oriented independently of the vessel. In particular, in the case of a stent in which the perforation area extends over the circumference of the stent, the stent can be inserted into a vessel in any orientation around its longitudinal axis at which vascular branches are present, since the perforation area means that the stent covers the vascular branch but still ensures perfusion.
[0016] According to one embodiment, the vascular prosthesis system can comprise at least one delivery device for delivering an agent that influences the flow properties of the blood into the human body. The delivery device is, in particular, a device by means of which the agent that influences the flow properties of the blood can be dosed, i.e., by means of which the amount and duration of delivery can be adjusted. One possible embodiment of the delivery device is thus a pump in which the delivery volume can be controlled. The delivery device is preferably a separate part of the vascular prosthesis system from the vascular prosthesis. Delivery into the bloodstream takes place at a suitable location, i.e., one that is easily accessible to the attending physician, for example, via a cannula that is inserted into a blood vessel in the arm. The agent that influences the flow properties of the blood is delivered systemically.
[0017] The agent influencing the flow properties of the blood can be or include an anticoagulant. This agent is preferably an anticoagulant, in particular heparin. The anticoagulant can also be referred to as a thrombin inhibitor, antiplatelet agent, or antithrombotic agent. The anticoagulation caused by the anticoagulant results in the blood not clotting or clotting more slowly. Thus, the addition of such an agent or at least the maintenance of a certain concentration of the agent maintains the blood's flowability. Alternatively or in addition to anticoagulants, blood thinning agents can also be used to reduce blood viscosity.Finally, an agent that has thrombosing properties or antagonizes an anticoagulant, such as heparin, can also be used to influence the flow properties of the blood. Such an antagonizing agent could be protamine, for example. By adding protamine, a heparin concentration in the blood that had previously been adjusted by adding heparin can be reduced.
[0018] By inhibiting blood clotting and / or reducing viscosity, the vascular prosthesis according to the invention can ensure blood flow through the holes into the branching blood vessels covered by the perforation area. This is important during the period in which the stent is placed in the branching blood vessel, since sufficient blood flow to the branching vessels or blood supply to the branching vessels is required during this time. By influencing the flow properties of the blood through the addition or supply of the agent, flow properties adapted to the current situation can be created. In particular, a desired concentration of an agent in the blood can be adjusted.
[0019] In addition, since the size of the holes is selected so that they can serve as a closure device, if the supply of the agent that influences the flow properties of the blood, in particular an anticoagulant or blood thinner, is reduced or completely stopped, the blood can close the hole(s) and thus prevent further passage of blood.
[0020] According to one embodiment, the size of the hole is therefore so small that untreated human blood or human blood slightly treated with an agent influencing the flow properties of the blood closes the hole after a certain flow time.
[0021] For the sake of simplicity, this description generally refers to one hole. However, it is understood that the statements—where applicable—apply to each of the multiple holes according to the invention. According to the invention, up to 100, preferably up to 15, holes can be provided, preferably 2, 3, 4, 56, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 25, 30, or more holes, whereby the inventive concept also encompasses numbers encompassed by the specified ranges but not explicitly listed.
[0022] In this context, untreated blood refers to blood to which no substance that affects the flow properties has been or will be added. Lightly treated blood, on the other hand, refers to blood to which small amounts of such a substance have been or will be added, or in which the concentration of the substance in the blood has been reduced. The condition of the blood is its current state. Thus, untreated blood may have been treated with the substance previously or may have had a higher concentration.
[0023] According to the invention, the hole has a diameter in the range of 1.0 mm to 1.3 mm. The hole particularly preferably has a diameter of 1.2 mm. The size of the hole is limited by the fact that it corresponds at least to the diameter of a guide wire that must be passed through the hole to insert the stent.
[0024] According to one embodiment, the size of the hole is large enough that at least blood treated with an agent that influences the flow properties of the blood can flow through the hole. The upper limit of the hole size is the diameter of the stent to be inserted. According to the invention, the size of the hole is always smaller than the diameter of the stent to be inserted. In addition, the upper limit of the hole size is the maximum addition limit for an agent that influences the flow properties of the blood. For example, with anticoagulants, there is a maximum limit above which bleeding can occur, i.e. blood can escape from the blood vessels. The size of the hole is therefore selected such that, with a permissible amount and duration of addition of the agent, blood flow through the hole is guaranteed.
[0025] According to the invention, the at least one hole further has a closed, i.e. continuous, circumferential edge made of the material of the vascular prosthesis. A closed (continuous) circumferential edge is one over which no material extends beyond the edge in the direction of the hole. In particular, no thread ends protrude beyond the edge into the hole. Furthermore, the edge is fixed, which means that the edge retains the shape of the hole. According to the invention and definition, the hole or the edge of the at least one hole is not formed by stitches, i.e. by crossing threads; by definition, a stitch does not have a circumferential, closed or continuous edge, but is defined by crossing threads that are not fixed at the intersection. The hole or holes according to the invention thus differ from a space between threads, i.e. stitches, of the material of the vascular prosthesis.As just discussed, these spaces are surrounded by threads of the material, but the threads are not fixed and therefore the threads can shift, which also changes the shape of the space.
[0026] However, with the edge provided according to the invention, the shape of the hole can be retained even when the vascular prosthesis is folded up for insertion into the main blood vessel, and this hole is then present in the desired shape at the branch from the main blood vessel for the passage of a guide wire.
[0027] According to a preferred embodiment, the edge of the hole(s) is / are thermally fixed. This can either be done by melting off protruding thread ends or by fixing threads displaced relative to each other by expanding the material of the vascular prosthesis.
[0028] According to the invention, at least one reinforcing means can be provided on the material of the vascular prosthesis, at least in the perforation area.
[0029] As explained above, the perforation area represents a type of closure device of the vascular prosthesis, as the hole(s) provided in the perforation area can close off blood flow due to their dimensions and design. By providing reinforcing elements, overstretching of the material of the vascular prosthesis in the perforation area can be prevented when one of the holes is expanded to insert a stent and when a stent is placed. This can further improve the hold of the stent on the vascular prosthesis and prevent blood leakage at the transition between the vascular prosthesis and the stent.
[0030] A "reinforcing means" is understood to mean any structure that is suitable for being attached to or in the perforation area and thereby provides it with stability that prevents the hole(s) from expanding.
[0031] According to one embodiment, the reinforcing means is preferably provided at intervals on the material of the vascular prosthesis and can, for example, be provided at an angle with respect to the longitudinal axis of the vascular prosthesis.
[0032] According to one embodiment, the reinforcement means is a reinforcement seam. Preferably, at least one of the holes is provided in the material of the vascular prosthesis between two reinforcement means. For this purpose, the reinforcement seams can preferably be provided in a crossed manner, so that rectangles or squares are formed between the seams. In each or some of these rectangles or squares, preferably several holes are introduced into the material of the vascular prosthesis.
[0033] As an alternative to reinforcing sutures, the reinforcing means can also be a reinforcing structure, for example a mesh or lattice structure. Such structures can also be referred to as stent-like structures. The use of such structures can, on the one hand, support the material of the vascular prosthesis and, on the other hand, stabilize the vascular prosthesis itself. The stent-like structure can, for example, be made of metal, plastic, or other known materials for medical devices that have a certain degree of flexibility to allow the vascular prosthesis to be folded for insertion into the vessel. The reinforcing means, which represents a stent-like structure, can, for example, be provided on the inside or outside of the material of the vascular prosthesis. However, it is also possible for the stent-like structure to be incorporated into the material of the vascular prosthesis, i.e., to lie within this material.
[0034] The invention is not limited to the described embodiments. For example, a larger mesh size of the material of the vascular prosthesis can be provided in the perforation area of the vascular prosthesis than in the other areas of the vascular prosthesis, particularly the spring area. This further simplifies the expansion for inserting and placing the vascular support.
[0035] As an alternative to a larger mesh size of the material in the perforation area, or in addition to this, it can also be provided that a weave type is used in the perforation area that differs from the weave type of the further area of the material of the vascular prosthesis, for example the spring area. Furthermore, it can be provided that the perforation area consists of adjacent sub-areas with different mesh sizes and / or different weave types. Different weave types are referred to as weave types. For example, in the perforation area or in a sub-area of the perforation area, a weave can be used in which the weft thread runs over at least two warp threads before being guided under the next warp thread. In particular, twill weaves and / or satin weaves can be used in the perforation area or in sub-areas of the perforation area.
[0036] The part of the material of the vascular prosthesis that lies outside the perforation area, for example in the spring area, can, for example, consist of a material in which the threads are connected to one another by a plain weave, i.e. in which the weft thread only runs over one warp thread before being guided under the next warp thread.
[0037] If different sub-areas in the perforation area are provided with different weave types, the particular advantage can be achieved that the expandability in the area of a hole through which a stent is to be guided and held can be determined by the weave type of one sub-area, but the expansion is prevented by an adjacent sub-area of a different weave, i.e. overstretching of the material of the vascular prosthesis by the stent can be prevented. In addition, the introduction of the holes in the perforation area is also simplified, since they can be specifically provided in areas or sub-areas where there are fewer weave points, for example in a sub-area with a satin weave. This simplifies expansion to form the hole.According to one embodiment, for example, rectangular sections can be formed in the perforation area, forming a checkerboard pattern, whereby the rectangular sections can alternate between satin and twill sections. By using different weaves or weaves, the insertion of the holes in the perforation area can be facilitated, while adjacent sections of different weaves or weaves can reliably prevent overstretching of the hole when inserting the stent.
[0038] According to a preferred embodiment, the vascular prosthesis system comprises, in addition to the vascular prosthesis, at least one stent. The stent is also referred to below as a stent. The stent is a covered stent, i.e., one provided with a material around its circumference.
[0039] According to one embodiment of the vascular prosthesis system according to the invention, the vascular support comprises a stent formed at one end by a cylindrical portion and having an enlarged portion with a larger diameter at the opposite end. The end with the enlarged portion is the end that is inserted into the vascular prosthesis when the stent is deployed. Providing such an enlarged portion ensures reliable anchoring of the stent to or in the vascular prosthesis. Furthermore, since the outer side of the stent rests against the edge of the hole in the material of the vascular prosthesis, the connection between the stent and the vascular prosthesis is additionally sealed.
[0040] The diameter of the stent in the cylindrical region preferably corresponds to the diameter of one of the holes in a stretched state. The stretched state is the state of the hole created by mechanically expanding the diameter of the hole, e.g. using a balloon. The stretching or widening of the hole occurs on the vascular prosthesis in the state in which it is already positioned in the main blood vessel. The cylindrical region can be equal to the diameter of one of the holes in the stretched state. Preferably, however, the cylindrical region is slightly larger than the hole in the stretched state. Such dimensioning of the cylindrical region of the stent, which is also referred to as oversizing, leads to a better hold of the stent in the hole. The diameter of the expanded region of the stent is preferably larger than the diameter of the hole in the stretched state.This dimensioning allows the expanded area to serve as an anchor, making it possible to insert and place the stent from the outside through the expanded hole into the vascular prosthesis. To insert the stent into the expanded hole, it is preferably initially in a folded state, for example, in a catheter, and expands automatically when the catheter is retracted. For this purpose, the stent has at least one spring element that is preloaded radially outward.
[0041] According to a further embodiment, it is provided that the vascular prosthesis and / or the vascular support comprises rings of meandering supports arranged one behind the other in their longitudinal direction, wherein the rings are not connected to each other but only via the vascular prosthesis material.
[0042] In this embodiment, individual stent rings, which point alternately in the proximal or distal direction, are connected to each other only indirectly via the vascular prosthesis material and not directly to each other.
[0043] According to one embodiment, stent rings are provided, in particular, at the proximal and / or distal end; these can be covered with vascular prosthesis material or attached to or in it, i.e., covered or uncovered.
[0044] According to a further aspect, the present invention relates to a method for producing a vascular prosthesis of a vascular prosthesis system according to the invention. The method, which is referred to below as the manufacturing method, is characterized in that after or during the introduction of the at least one hole into the material of the vascular prosthesis, a thermal treatment of the material of the vascular prosthesis takes place at least in the region of the at least one hole. Thermal treatment is referred to in particular as warming or heating the material. In this case, the material of the vascular prosthesis can melt at least in some regions. By thermally treating the material, in particular the edge of the hole can be fixed and any excess threads or the like can be removed.
[0045] The holes are made in the material of the vascular prosthesis before the vascular prosthesis is inserted into the main blood vessel.
[0046] According to one embodiment of the manufacturing method according to the invention, the at least one hole is created using a tool. The tool can be a punching tool. However, a non-destructive manufacturing method is preferably used, in which the tool comprises, for example, a needle or cannula. This can be inserted into the material of the vascular prosthesis and thereby displace the threads of the material of the vascular prosthesis.
[0047] According to one embodiment, when using a tool comprising at least one needle, the needle(s) are heated before insertion into the material of the vascular prosthesis. Alternatively, the needle(s) can also be heated after insertion. Instead of needles, hollow needles or cannulas, for example, can also be used in the method according to the invention.
[0048] As an alternative to a contact tool, such as a punching tool or a tool with needles or cannulas, the at least one hole can also be made using contactless tools, in particular a laser tool. In this case, the hole is made using a laser beam directed onto the material of the vascular prosthesis. With this type of introduction, too, the edge of the hole is preferably welded or sealed due to an elevated temperature generated by the laser. Thus, with this type of introduction using a laser, the material of the vascular prosthesis is thermally treated, at least in the region of the at least one hole, while the at least one hole is being made in the material of the vascular prosthesis.
[0049] Also disclosed herein is a method for inserting a vascular prosthesis of a vascular prosthesis system into a major blood vessel of a human. The method, also referred to below as the insertion method, is characterized in that the vascular prosthesis is inserted into a major blood vessel of a human body and an agent influencing the flow properties of the blood is introduced into the bloodstream.
[0050] The sequence of insertion of the vascular prosthesis and delivery of the agent to influence blood flow properties is not limited to a specific order. Thus, the agent can be delivered before the vascular prosthesis is inserted. Alternatively, the vascular prosthesis can be inserted first and the agent can be delivered subsequently. Finally, delivery can also begin during the insertion of the vascular prosthesis.
[0051] What is essential, however, is that it is a supply, i.e., a targeted addition that can be varied in time and quantity. The mere provision of a means for influencing the flow properties of the blood at the vascular prosthesis therefore does not constitute supply within the meaning of the disclosure, since a targeted variation of the quantity over time is not possible, nor can the quantity be specifically varied, in particular, reduced.
[0052] For example, the agent that influences the flow properties of the blood can be added over a period of time and in an amount sufficient to allow blood to flow through at least one hole in the vascular prosthesis. In the case of an anticoagulant, the amount of the agent added, or at least the concentration of the agent in the blood, is increased over a certain period of time. This prevents or at least inhibits blood clotting, which could lead to the hole(s) becoming clogged.
[0053] The vascular prosthesis is inserted, for example, using a catheter into which the vascular prosthesis is accommodated. The vascular prosthesis is released at the desired position, i.e., released from the catheter. The position at which the vascular prosthesis is released is preferably in the region of a branch of one or more branch vessels from the main blood vessel. The vascular prosthesis is positioned so that the perforation area of the vascular prosthesis covers the branch or branches. By adding agents to influence the flow properties of the blood, it can be ensured that blood can continue to flow through the holes in the perforation area of the vascular prosthesis into the branch vessels, i.e. that perfusion is still guaranteed in the perforation area.
[0054] A guide wire can be passed through the main blood vessel or through a branch vessel through the perforation area of the vascular prosthesis through one of the holes and the hole is widened using a balloon.
[0055] After one of the holes in the vascular prosthesis has been expanded, a stent, for example, is inserted at least partially into the expanded hole of the vascular prosthesis via the main blood vessel or a branch vessel and released. Release is understood to mean the expansion of the stent, which in the case of a self-expanding stent can occur, for example, by retracting a catheter containing the stent.
[0056] After the stent has been inserted by reducing the amount of agent that influences the flow properties of the blood, at least one of the holes in the vascular prosthesis is closed. In this case, only the holes in which no stent was provided are closed. The hole that was widened and into which the stent was inserted is held open by the stent and kept in the widened state. Since the diameter of the stent is preferably larger than the diameter of the hole in the widened state, the stent is held in place by resting on the edge of the hole. If a stent with an enlarged area at one end is also used, this enlarged area can also serve to hold the stent to the vascular prosthesis.
[0057] At the holes where no stent is inserted, the reduced flow of the agent influencing the blood flow properties leads to closure of the holes. If an anticoagulant is used, reducing the flow of the agent will cause clotting, leading to the clogging of the holes. If the agent is a blood thinner, reducing the flow of the agent will reduce the viscosity of the blood until it can no longer pass through the holes.
[0058] The reduction in the supply of the agent influencing the flow properties of the blood occurs after the release of the vascular support.
[0059] Instead of reducing the amount of the agent that affects blood flow properties, another agent that affects blood flow properties can also be added. This other agent, for example, counteracts the effect of a previously added agent and / or reduces the concentration of the previously added agent in the blood. For example, heparin can be added first and then protamine can be added to reduce the heparin concentration in the blood.
[0060] The agent that influences the flow properties of the blood is preferably added in a time and quantity sufficient to specifically influence the closure of at least one of the holes. The addition or supply is determined, for example, according to the following formula: V = L K ƒB V <none / > 0 10.000
[0061] The closure is therefore a function of the hole size (Lk), which is constant, and the delivery of the agent influencing the blood flow properties (Bv). The delivery of the agent influencing the blood flow properties can be varied within the limits of 0 to 10,000. These limits can be expressed as values in IU / ml and refer specifically to the agent heparin. The dosage of heparin is given in IU (International Units). 1,000 IU can render 1 liter of sheep or bovine blood anticoagulable for one hour at 37°C.
[0062] During or after insertion of the vascular prosthesis into the main blood vessel, heparin, for example, can be administered in an amount of more than 0.75 IU / ml. This means that with a normal human blood volume of 6 liters, at least 4500 IU of heparin must be administered or retained in the body. In this state, particularly with a hole size in the opened area, the holes can be kept open, meaning blood can flow into the branch vessels. After insertion of the stent, the holes in the perforation area not occupied by the stent should be closed. For this purpose, heparin can be added or the concentration of heparin in the blood can be reduced to a value below 0.75 IU / ml. It has been shown that with this amount of heparin, the closure of the holes in the perforation area begins through coagulation of the blood.
[0063] The critical value of the so-called Activated Clotting Time (ACT) of blood is in the range of 150 to 250 seconds, for example, 200 seconds. As long as an ACT value is achieved that is above the critical value, the holes in the perforation area remain open. If the ACT value drops below the critical value, the holes begin to close, thus sealing the vascular prosthesis.
[0064] The invention will be described in more detail below with reference to the accompanying drawings. Figure 1: a schematic representation of an embodiment of a vascular prosthesis of the vascular prosthesis system according to the invention; Figure 2: a schematic detailed representation of a part of the perforation area of the embodiment of the vascular prosthesis according to Figure 1 ; Figure 3: a schematic detailed representation of the part of the perforation area of the embodiment of the vascular prosthesis according to Figure 2in the expanded state of the hole; Figure 4: a schematic representation of an embodiment of the introduction of a hole in the material of a vascular prosthesis; Figure 5: a schematic representation of another embodiment of the introduction of a hole in the material of a vascular prosthesis; Figure 6: a schematic representation of the use of an embodiment of the vascular prosthesis according to the invention in the region of the renal artery; Figure 7: a schematic representation of the use of an embodiment of the vascular prosthesis according to the invention in the region of the common artery; Figure 8: a schematic representation of the use of an embodiment of the vascular prosthesis according to the invention in the region of the carotid artery and subclavian artery; Figure 9: a schematic representation of the use of an embodiment of the vascular prosthesis according to the invention in the region of the carotid artery and subclavian artery according to Figure 8during insertion of a vascular support; and Figure 10: a schematic representation of an embodiment of a vascular support of the vascular prosthesis system according to the invention.
[0065] In Figure 1 A schematic representation of an embodiment of a vascular prosthesis 1 of the vascular prosthesis system 50 according to the invention is shown. In the illustrated embodiment, the vascular prosthesis 1 has an elongated hollow cylindrical base body 5 with a proximal end 3 and a distal end 4. At the ends 3, 4 of the vascular prosthesis 1, spring regions 11 are provided, in which spring elements 110 are fastened in or on the material 12 of the vascular prosthesis 1. Between the spring regions 11, a perforation region 10 is provided, which has a length a. In this perforation region 10, holes 100 are introduced into the material 12 of the vascular prosthesis 1, which holes represent closure devices according to the invention.
[0066] Furthermore, in the Fig. 1In the example of the vascular prosthesis according to the invention shown, reinforcing means 101 in the form of intersecting reinforcing seams are provided in the perforation region 10. The reinforcing seams are arranged such that checks are formed between them. As an alternative to the reinforcing seams shown, a stent-like reinforcing structure (not shown) can also be provided on the material 12 of the vascular prosthesis 1 or incorporated into this material 12. In addition, at least a partial region in the perforation region 10 or the entire perforation region 10 can have a weave type that differs from the weave type of the spring regions 11. If partial regions are formed, these can be square, for example, so that the distribution of the partial regions in the perforation region 10 results in a checkerboard pattern.
[0067] The distribution of the holes 100 in the Figure 1 shown checks are in Figure 2 shown in more detail. As can be seen from the Figure 2results, holes 100 are made in an area which has a longitudinal and width dimension Y and is therefore preferably rectangular, said holes having a diameter x which is smaller than Y. Y represents the vertical distance between two reinforcing seams. The perforation area 10, over which the holes are provided in the length of the vascular prosthesis 1, extends over a length a which is greater than the bisector of the area of the diamond with the length and width Y.
[0068] Will, as in Figure 3 As shown, a hole 100a is widened by inserting a guide wire 13 and expanding a balloon (not shown) provided thereon, the expansion of the hole 100a is limited by the reinforcing means 101. The further holes 100b, which are in a diamond shape with the expanded hole, are compressed when the hole 100a is expanded, i.e., reduced in size, and form slit-like shapes, as in Fig. 3 shown.
[0069] In Figure 4 A schematic representation of an embodiment of the introduction of a hole 100 into the material 12 of a vascular prosthesis 1 according to the invention is shown. The hole 100 is created, for example, by punching or cutting out the material 12 of the vascular prosthesis 1. The material 12 of the vascular prosthesis 1 is shown schematically here by woven threads 17. The circumference of the hole 100 is formed by an edge 102. In the Figure 4 In the embodiment shown, the thread ends present at the periphery of the hole 100 are welded or fused together. For this purpose, for example, a heated needle or cannula (not shown) can be inserted into the hole 100 for a time sufficient to weld the thread ends together.
[0070] In Figure 5A schematic representation of another embodiment of the introduction of a hole 100 into the material 12 of a vascular prosthesis 1 is shown. In this embodiment, the hole 100 is introduced non-destructively into the material 12 of the vascular prosthesis 1. In particular, a needle 2 is inserted into the material 12, thereby displacing the threads 17 of the material 12 outward. By heating the needle 2, the thus formed relative position of the threads 17 to one another can be fixed, thus forming the edge 102 of the hole 100. Alternatively, the hole 100 can also be introduced into the material 12 of the vascular prosthesis 1 by laser treatment.
[0071] In Figure 6 is a schematic representation of an exemplary stenting of the renal artery 25 with an embodiment of the vascular prosthesis 1 according to the invention. On the main blood vessel V of the renal artery 25, Figure 6schematically shows a defect in the form of an aneurysm A. In order to relieve this and prevent failure of the main blood vessel V, the vascular prosthesis 1 is introduced into the main blood vessel V. The vascular prosthesis 1 is positioned so that the covered spring area 11 shown in the exemplary embodiment covers the aneurysm A. However, spring elements do not necessarily have to be provided in the area in which the spring area 11 rests against the aneurysm A. In Figure 6 For the sake of clarity, no spring elements are shown. The perforation area 10 is located at the branch vessels B, which are also called outlet vessels and are Figure 6 represent the renal arteries.
[0072] It is understood that in the Fig. 6The example shown, the renal artery, is only an exemplary vessel. The vascular prosthesis system according to the invention can be inserted into any vessel with the aim of reliably supplying blood to side vessels branching off from the vessel when a vascular prosthesis is inserted into the vessel and threatens to block the side vessels.
[0073] Before, during, or after positioning the vascular prosthesis 1, an agent that influences the flow properties of the blood is systemically introduced into the bloodstream. The holes 100 of the perforation area 10 are thereby kept open.
[0074] A guide wire (not shown) can be guided through the thus positioned vascular prosthesis 1 and guided in the perforation area 10 through one of the holes 100 provided therein into one of the branch vessels B. Subsequently, the hole 100 through which the guide wire was guided can be mechanically widened, for example by means of a balloon (not shown). Subsequently, a vascular support (in Fig. 6 (not shown) through the widened hole 100 into the branch vessel B and released there. After the stent is inserted, the supply of the agent for influencing the flow properties of the blood is reduced, or the concentration of the agent in the blood is reduced in another way, for example, by adding another agent. As a result, the other holes 100 in which no stent is provided are closed in the perforation area 10, and the path of the blood is determined by the vascular prosthesis 1 and the stent.
[0075] In Figure 7 A schematic representation of a stent in the area of the common artery 26 using an embodiment of the vascular prosthesis 1 according to the invention is shown. This figure also shows only the vascular prosthesis 1 in the position required for placing the stent, and not the stent itself. The vascular prosthesis 1 is inserted into the common carotid artery 26, or the main vessel V, and the perforation area 10 covers the branch to the external carotid artery 27, or the branch vessel B. The holes 100 in the perforation area 10 are not shown in this view.
[0076] In Figure 8A schematic representation of a stent in the area of the carotid artery and subclavian artery branching from the aortic arch 29 is shown, using an embodiment of the vascular prosthesis 1 according to the invention. Here, the vascular prosthesis 1 is inserted into the aortic arch 29, and the perforation area 10 covers the right and left common carotid arteries 31, 32 and the subclavian artery 33. In this embodiment, the perforation area 10 of the vascular prosthesis 1 thus extends over (all) three branches.
[0077] As can be seen from Figure 9 which shows a schematic representation of the stenting of the carotid arteries 31, 32 and subclavian artery 33 after Figure 8 when inserting a vascular support 14 into the right common carotid artery, with the present invention the vascular support 14 can be brought to the vascular prosthesis 1 from the outside.
[0078] An embodiment of the vascular support 14, for example a stent, is shown schematically in Figure 10shown. The stent 14, which comprises a hollow cylindrical stent base body 35, a longitudinal axis 36, and a circumference 37, has a first stent end 38 with a first diameter d and a second stent end 39 with a second diameter e, which is also referred to herein as an enlarged region 141. This stent 14 can be inserted from the outside into the vascular prosthesis 1 through a previously widened hole 100 in the perforation region 10 and, after the stent 14 has been released, is held on or in the vascular prosthesis 1 by the enlarged region 141.
[0079] Even in the embodiments according to Figure 7, 8 and 9Before, during, or after positioning the vascular prosthesis 1, an agent influencing the flow properties of the blood is systemically introduced into the bloodstream and monitored. The holes 100 of the perforation area 10 are thereby kept open. After the vascular support 14 is placed, the supply of the agent influencing the flow properties of the blood is reduced, or the concentration of the agent in the blood is reduced in another way, for example, by adding another agent. This closes the other holes 100 in the perforation area 10, and the path of the blood is determined by the vascular prosthesis 1 and the vascular support 14.
[0080] In the vascular prosthesis 1 according to the invention, the holes 100 are thus closed by influencing the flow properties, in particular the coagulation behavior of the blood. As discussed above, the holes 100 close after the supply of the agent for influencing the flow properties is discontinued.
[0081] Branch vessels or outgoing vessels B are covered in the vascular prosthesis 1 according to the invention. However, since the perforation area with the holes is provided in this region, the blood flow to or from the branching vessel B is not impeded. For this purpose, the tendency of the blood to clot is preferably influenced. Alternatively or additionally, the blood is thinned. Known anticoagulants or blood thinners can be added for this purpose. Heparin is preferably used. In this state, in which the holes are kept open by the blood thinning, a wire with a balloon, in particular a dilatation balloon, can be guided through one of the holes 100 in the vascular prosthesis 1, since the perforation area 10 of the vascular prosthesis 1 was placed in the region of the branch. The wire with the balloon is used to widen the hole 100 through which it was guided.A vascular support 14, in particular a covered stent, is then inserted through the thus widened hole 100. The stent extends from the widened hole in the direction of the branching vessel B and is thus located in the branching vessel B.
[0082] Thus, intraoperative fenestration can be performed with the present invention.
[0083] According to a preferred embodiment, seams or a stent-like reinforcement structure 101 are provided in the perforation area 10, which limit a widening of the holes in the material 12 of the vascular prosthesis 1, which can also be referred to as graft material and is in particular Drakon or another cloth material.
[0084] In the perforation area 10, the vascular prosthesis 1 can be braided or woven more coarsely. This simplifies the widening of the holes 100 using the balloon. Additionally or alternatively, different weave types can also be present in the perforation area 10, for example, twill and satin.
[0085] The inventors have recognized that there is a relationship between the hole size / hole diameter x, the blood dilution, and the resulting closure of the hole 100. In particular, the closure is a function of the constant hole size / hole diameter x and the course of the blood dilution.
[0086] In the disclosed insertion method and with the vascular prosthesis 1 according to the invention, a stent, in particular a covered stent, can preferably be used as the vascular support 14. This stent has a shape in which one end of the stent, in the inserted state, has a larger diameter than the rest of the stent. In particular, the stent can have a trumpet shape. The region 141 of the vascular support / stent, which has the larger diameter, rests against the inside of the vascular prosthesis 1 in the inserted state, while the rest of the stent is located in the branching vessel B.
[0087] The procedure for inserting the stent / vascular support 14 is as follows. First, the stent / vascular support 14 is inserted into the vessel, for example, into the aorta in the region of the aortic arch 29. The perforation area 10, in which the holes 100 are made in the material 12 of the vascular prosthesis 1, covers the outgoing vessels B, in particular the carotid arteries 31, 32 and subclavian arteries 33. In this state, a wire can be inserted against the blood flow directed into the outgoing vessels. The wire is guided through one of the holes 100, and the hole 100 is expanded using the balloon provided or guided on the wire. A stent / vascular support 14 can then be inserted over the wire until its distal end lies in the vascular prosthesis 1. In this state, the stent / vascular support 14 can be released. Upon release, the stent / vascular support 14 expands and is thereby secured to or in the vascular prosthesis 1.The preferred shape of the stent / vascular support 14, particularly the trumpet shape, can further improve the hold of the stent / vascular support 14 on the vascular prosthesis 1. The region with a larger diameter 141 extends beyond the hole 100 into the interior of the vascular prosthesis 1. When the stent / vascular support 14 is released, it expands, and the region with the larger diameter 141 acts as an anchor.
[0088] After the stent / vascular support 14 has been deployed, the invention provides for the perforation area 10 to be closed. This is achieved by influencing the flow properties of the blood, in particular by adjusting blood thinning or coagulation.
[0089] In order to influence the flow properties of the blood and thus to specifically close holes 100 in an area of the vascular prosthesis 1, a blood thinner or anticoagulant can be added in different dosages or the dosage of the blood thinner or anticoagulant can be varied or the concentration of the agent in the blood can be reduced in another way, for example by adding another agent.
[0090] The anticoagulant can be heparin, for example. In a range of 7,000 to 10,000 units (IU / ml), it has been shown that the holes 100 in the vascular prosthesis 1 can be reliably kept open, thus preventing blood congestion or the cutting off of the blood supply to certain blood vessels during the insertion of the vascular prosthesis 1 and the placement of one or more stents / vascular supports 14 on the vascular prosthesis 1.
[0091] Thus, a combination of a suitable hole diameter x and the blood condition can be selected, which specifically leads to the closure of the holes 100. Closure of the holes 100 is required after the deployment of the stent(s) / vascular support(s) 14.
Claims
1. A vessel prosthesis system (50) comprising at least one vessel prosthesis (1) for introduction into a blood vessel of a human body, wherein the vessel prosthesis (1) comprises a proximal end (3), a distal end (4), an oblong hollow cylindrical main body (5) extending in between the proximal end (3) and the distal end (4) having a longitudinal axis c and a circumference b, which main body (5) comprises a vessel prosthesis material (12) for forming a circumferentially substantially closed cover (19), wherein the vessel prosthesis material (12) comprises a fabric structure (18) from interwoven threads (17) and having a mesh density (16), characterised in that the vessel prosthesis (1) comprises, within the vessel prosthesis material (12), at least one perforation area (10) located in between the proximal end (3) and the distal end (4) with a plurality of perforations (100) comprising a diameter x selected from a range of 1.0 mm to 1.3 mm and wherein the plurality of perforations (100) comprise a closed circumferential rim (102), over which rim (102) no vessel prosthesis material (12) extends in the direction of the perforations (100) beyond the rim (102).
2. The vessel prosthesis system (50) of claim 1, characterized in that the perforations (100) comprise a diameter x of 1.2 mm.
3. The vessel prosthesis system (50) of any one of the preceding claims, characterized in that the closed circumferential rim (102) of the plurality of perforations (100) consists of vessel prosthesis material (12), wherein the rim (102) is preferably thermally fixed.
4. The vessel prosthesis system (50) of any one of the preceding claims, characterized in that the perforation area (10) extends with respect to the longitudinal axis of the vessel prosthesis (1) only over a part of the vessel prosthesis (1).
5. The vessel prosthesis system (50) of any one of the preceding claims, characterized in that the perforation area (10) is dimensioned with respect to the circumference b of the vessel prosthesis (1) such that it extends over at least a part of the circumference b or over the total circumference b.
6. The vessel prosthesis system (50) of any one of the preceding claims, characterized in that the in the perforation area (10) further at least one reinforcement means (101) are provided at the vessel prosthesis material (12).
7. The vessel prosthesis system (50) of claim 6, characterized in that the reinforcement means (101) is selected from a reinforcement suture or a reinforcement structure.
8. The vessel prosthesis system (50) of any one of claims 6 or 7, characterized in that in between of two reinforcement means (101) at least one perforation (100) is provided in the vessel prosthesis material (12).
9. The vessel prosthesis system (50) of any one of claims 1 to 8, characterized in that it further comprises a vessel support (14) with a longitudinal axis (36), a circumference (37), and a hollow cylindrical vessel support main body (35), which vessel support (14) further comprises a first vessel support end (38) having a first diameter d and a second vessel support end (39) having a second diameter e, and which vessel support (14) is introducible via the second vessel support end (39) into a perforation (100) of the plurality of perforations (100) in the perforation area (10).
10. The vessel prosthesis system (50) of claim 9, characterized in that the second vessel support end (39) of the vessel support (14) comprises a larger diameter e than the first vessel support end (38) of the vessel support (14).
11. The vessel prosthesis system (50) of any one of the preceding claims, characterized in that the vessel prosthesis (1) and / or the vessel support (14) comprises in its longitudinal direction (c; 36) successively arranged rings from meandering circumferential supports, wherein the rings are not connected with each other but only via the vessel prosthesis material (12).
12. The vessel prosthesis system (50) of any one of the preceding claims, characterized in that it further comprises an introduction system for introduction of at least one agent influencing the flow properties of blood into the human body.
13. A method for production of a vessel prosthesis system (50) of any one of claims 1 to 12, characterized in that it comprises the step of putting in, in the prosthesis material (12), a plurality of perforations (100) having a diameter x selected from a range of 1.0 mm to 1.3 mm (100), wherein after or during the putting in of the plurality of perforations (100) a thermal treatment of the vessel prosthesis material (12) is performed in the area of the plurality of perforations (100).
14. The method of claim 13, characterized in that the plurality of perforations (100) is put in by means of a laser tool or a tool that comprises at least one needle.
